Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2793 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.030 | 0.667 | 3 | 2005 | 2014 | ||||
Malignant neoplasm of breast
|
3417 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.030 | 0.667 | 3 | 2005 | 2014 | ||||
Malignant neoplasm of prostate
|
1082 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.030 | 1.000 | 3 | 2009 | 2015 | ||||
Prostate carcinoma
|
1168 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.030 | 1.000 | 3 | 2009 | 2015 | ||||
Dementia, Vascular
|
32 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.020 | 1.000 | 2 | 2009 | 2012 | ||||
Depressed mood
|
269 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.020 | 1.000 | 2 | 2011 | 2018 | ||||
Depressive disorder
|
297 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.020 | 1.000 | 2 | 2011 | 2018 | ||||
Endometriosis
|
274 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.020 | 0.500 | 2 | 2008 | 2014 | ||||
Graves Disease
|
352 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.020 | 1.000 | 2 | 2008 | 2011 | ||||
Mental Depression
|
271 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.020 | 1.000 | 2 | 2011 | 2018 | ||||
Metabolic Syndrome X
|
591 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.020 | 1.000 | 2 | 2009 | 2012 | ||||
Alzheimer's Disease
|
1843 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Bile duct carcinoma
|
10 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Cardiovascular Diseases
|
711 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Cerebrovascular accident
|
591 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Cholangiocarcinoma
|
43 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Colorectal Carcinoma
|
1962 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Coronary Arteriosclerosis
|
440 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Coronary Artery Disease
|
1577 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Coronary heart disease
|
1178 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Glaucoma
|
198 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Gynecomastia
|
8 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Hepatitis C
|
347 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Hyperlipidemia
|
83 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.010 | 1 | 2010 | 2010 | |||||
Lipodystrophy
|
28 | 0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 | 0.010 | 1.000 | 1 | 2012 | 2012 |